nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorprothixene—HTR2A—conduct disorder	0.837	1	CbGaD
Chlorprothixene—Chlordiazepoxide—GABRA2—conduct disorder	0.000832	0.0703	CrCbGaD
Chlorprothixene—Cinolazepam—GABRA2—conduct disorder	0.000686	0.058	CrCbGaD
Chlorprothixene—Adinazolam—GABRA2—conduct disorder	0.000574	0.0485	CrCbGaD
Chlorprothixene—Fludiazepam—GABRA2—conduct disorder	0.000569	0.048	CrCbGaD
Chlorprothixene—Flurazepam—GABRA2—conduct disorder	0.000518	0.0437	CrCbGaD
Chlorprothixene—Triazolam—GABRA2—conduct disorder	0.000517	0.0437	CrCbGaD
Chlorprothixene—Propiomazine—DRD4—conduct disorder	0.000506	0.0428	CrCbGaD
Chlorprothixene—Temazepam—GABRA2—conduct disorder	0.000495	0.0418	CrCbGaD
Chlorprothixene—Midazolam—GABRA2—conduct disorder	0.00048	0.0405	CrCbGaD
Chlorprothixene—Cyamemazine—HTR2A—conduct disorder	0.000454	0.0384	CrCbGaD
Chlorprothixene—Methotrimeprazine—DRD4—conduct disorder	0.000433	0.0366	CrCbGaD
Chlorprothixene—Cyclobenzaprine—HTR2A—conduct disorder	0.000422	0.0357	CrCbGaD
Chlorprothixene—Diazepam—GABRA2—conduct disorder	0.000411	0.0347	CrCbGaD
Chlorprothixene—Chlorphenamine—SLC6A4—conduct disorder	0.000384	0.0325	CrCbGaD
Chlorprothixene—Promazine—DRD4—conduct disorder	0.000375	0.0317	CrCbGaD
Chlorprothixene—Chlorpromazine—DRD4—conduct disorder	0.00033	0.0279	CrCbGaD
Chlorprothixene—Zuclopenthixol—HTR2A—conduct disorder	0.000326	0.0275	CrCbGaD
Chlorprothixene—Acepromazine—HTR2A—conduct disorder	0.000292	0.0247	CrCbGaD
Chlorprothixene—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000292	0.00194	CbGpPWpGaD
Chlorprothixene—Clomipramine—SLC6A4—conduct disorder	0.000289	0.0244	CrCbGaD
Chlorprothixene—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000287	0.00191	CbGpPWpGaD
Chlorprothixene—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.000285	0.0019	CbGpPWpGaD
Chlorprothixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000284	0.00189	CbGpPWpGaD
Chlorprothixene—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.000283	0.00188	CbGpPWpGaD
Chlorprothixene—HTR2B—G alpha (q) signalling events—HTR2A—conduct disorder	0.000283	0.00188	CbGpPWpGaD
Chlorprothixene—Nortriptyline—SLC6A4—conduct disorder	0.000282	0.0238	CrCbGaD
Chlorprothixene—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000281	0.00187	CbGpPWpGaD
Chlorprothixene—Thiothixene—HTR2A—conduct disorder	0.000281	0.0237	CrCbGaD
Chlorprothixene—CHRM5—G alpha (q) signalling events—HTR2A—conduct disorder	0.00028	0.00186	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000278	0.00185	CbGpPWpGaD
Chlorprothixene—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000276	0.00184	CbGpPWpGaD
Chlorprothixene—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000274	0.00182	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR ligand binding—CGA—conduct disorder	0.000273	0.00182	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.000272	0.00181	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR ligand binding—CGA—conduct disorder	0.000271	0.0018	CbGpPWpGaD
Chlorprothixene—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000271	0.0018	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000271	0.0018	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.000269	0.00179	CbGpPWpGaD
Chlorprothixene—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000267	0.00178	CbGpPWpGaD
Chlorprothixene—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000257	0.00171	CbGpPWpGaD
Chlorprothixene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000253	0.00168	CbGpPWpGaD
Chlorprothixene—Doxepin—SLC6A4—conduct disorder	0.000253	0.0214	CrCbGaD
Chlorprothixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000251	0.00167	CbGpPWpGaD
Chlorprothixene—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.000249	0.00165	CbGpPWpGaD
Chlorprothixene—HTR6—GPCR downstream signaling—CGA—conduct disorder	0.000242	0.00161	CbGpPWpGaD
Chlorprothixene—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00024	0.00159	CbGpPWpGaD
Chlorprothixene—HTR6—GPCR ligand binding—DRD4—conduct disorder	0.00024	0.00159	CbGpPWpGaD
Chlorprothixene—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000239	0.00159	CbGpPWpGaD
Chlorprothixene—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000235	0.00156	CbGpPWpGaD
Chlorprothixene—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000234	0.00156	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000234	0.00155	CbGpPWpGaD
Chlorprothixene—Propiomazine—HTR2A—conduct disorder	0.000233	0.0197	CrCbGaD
Chlorprothixene—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000233	0.00155	CbGpPWpGaD
Chlorprothixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000232	0.00154	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000231	0.00153	CbGpPWpGaD
Chlorprothixene—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000228	0.00152	CbGpPWpGaD
Chlorprothixene—CHRM4—GPCR downstream signaling—CGA—conduct disorder	0.000228	0.00152	CbGpPWpGaD
Chlorprothixene—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000226	0.0015	CbGpPWpGaD
Chlorprothixene—CHRM4—GPCR ligand binding—DRD4—conduct disorder	0.000226	0.0015	CbGpPWpGaD
Chlorprothixene—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000225	0.0015	CbGpPWpGaD
Chlorprothixene—Clomipramine—HTR2A—conduct disorder	0.000222	0.0187	CrCbGaD
Chlorprothixene—HTR2B—GPCR downstream signaling—CGA—conduct disorder	0.000221	0.00147	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling by GPCR—CGA—conduct disorder	0.00022	0.00146	CbGpPWpGaD
Chlorprothixene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000219	0.00145	CbGpPWpGaD
Chlorprothixene—HTR2B—GPCR ligand binding—DRD4—conduct disorder	0.000219	0.00145	CbGpPWpGaD
Chlorprothixene—CHRM5—GPCR downstream signaling—CGA—conduct disorder	0.000219	0.00145	CbGpPWpGaD
Chlorprothixene—Nortriptyline—HTR2A—conduct disorder	0.000217	0.0183	CrCbGaD
Chlorprothixene—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000217	0.00144	CbGpPWpGaD
Chlorprothixene—CHRM5—GPCR ligand binding—DRD4—conduct disorder	0.000217	0.00144	CbGpPWpGaD
Chlorprothixene—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000208	0.00138	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling by GPCR—CGA—conduct disorder	0.000207	0.00138	CbGpPWpGaD
Chlorprothixene—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000206	0.00137	CbGpPWpGaD
Chlorprothixene—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000206	0.00137	CbGpPWpGaD
Chlorprothixene—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.000205	0.00137	CbGpPWpGaD
Chlorprothixene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000205	0.00137	CbGpPWpGaD
Chlorprothixene—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000205	0.00136	CbGpPWpGaD
Chlorprothixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000204	0.00136	CbGpPWpGaD
Chlorprothixene—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000204	0.00135	CbGpPWpGaD
Chlorprothixene—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000204	0.00135	CbGpPWpGaD
Chlorprothixene—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000201	0.00134	CbGpPWpGaD
Chlorprothixene—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000201	0.00134	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling by GPCR—CGA—conduct disorder	0.000201	0.00133	CbGpPWpGaD
Chlorprothixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0002	0.00133	CbGpPWpGaD
Chlorprothixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0002	0.00133	CbGpPWpGaD
Chlorprothixene—Methotrimeprazine—HTR2A—conduct disorder	0.0002	0.0169	CrCbGaD
Chlorprothixene—CHRM5—Signaling by GPCR—CGA—conduct disorder	0.000198	0.00132	CbGpPWpGaD
Chlorprothixene—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000198	0.00132	CbGpPWpGaD
Chlorprothixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000198	0.00131	CbGpPWpGaD
Chlorprothixene—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000197	0.00131	CbGpPWpGaD
Chlorprothixene—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	0.000197	0.00131	CbGpPWpGaD
Chlorprothixene—Promethazine—HTR2A—conduct disorder	0.000197	0.0166	CrCbGaD
Chlorprothixene—Amitriptyline—SLC6A4—conduct disorder	0.000196	0.0165	CrCbGaD
Chlorprothixene—Doxepin—HTR2A—conduct disorder	0.000195	0.0164	CrCbGaD
Chlorprothixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000194	0.00129	CbGpPWpGaD
Chlorprothixene—Perphenazine—HTR2A—conduct disorder	0.000192	0.0162	CrCbGaD
Chlorprothixene—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000189	0.00126	CbGpPWpGaD
Chlorprothixene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000188	0.00125	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling by GPCR—CGA—conduct disorder	0.000187	0.00124	CbGpPWpGaD
Chlorprothixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000186	0.00123	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000178	0.00118	CbGpPWpGaD
Chlorprothixene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000177	0.00118	CbGpPWpGaD
Chlorprothixene—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000177	0.00118	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000177	0.00117	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000177	0.00117	CbGpPWpGaD
Chlorprothixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000176	0.00117	CbGpPWpGaD
Chlorprothixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000176	0.00117	CbGpPWpGaD
Chlorprothixene—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000174	0.00116	CbGpPWpGaD
Chlorprothixene—Promazine—HTR2A—conduct disorder	0.000173	0.0146	CrCbGaD
Chlorprothixene—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000162	0.00108	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000157	0.00105	CbGpPWpGaD
Chlorprothixene—HTR6—GPCR ligand binding—HTR2A—conduct disorder	0.000156	0.00104	CbGpPWpGaD
Chlorprothixene—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000156	0.00104	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000156	0.00104	CbGpPWpGaD
Chlorprothixene—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000155	0.00103	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000154	0.00103	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.000154	0.00102	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.000153	0.00102	CbGpPWpGaD
Chlorprothixene—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000153	0.00102	CbGpPWpGaD
Chlorprothixene—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000153	0.00102	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000153	0.00102	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000152	0.00101	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.000152	0.00101	CbGpPWpGaD
Chlorprothixene—Chlorpromazine—HTR2A—conduct disorder	0.000152	0.0129	CrCbGaD
Chlorprothixene—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000152	0.00101	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000152	0.00101	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.000152	0.00101	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.000152	0.00101	CbGpPWpGaD
Chlorprothixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000151	0.00101	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000151	0.001	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.000151	0.001	CbGpPWpGaD
Chlorprothixene—Amitriptyline—HTR2A—conduct disorder	0.00015	0.0127	CrCbGaD
Chlorprothixene—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	0.000148	0.000981	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000143	0.000949	CbGpPWpGaD
Chlorprothixene—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	0.000143	0.000949	CbGpPWpGaD
Chlorprothixene—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	0.000141	0.000939	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.00014	0.000934	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling by GPCR—CGA—conduct disorder	0.00014	0.000932	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.00014	0.000929	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.000139	0.000926	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.000138	0.000917	CbGpPWpGaD
Chlorprothixene—HTR6—GPCR downstream signaling—DRD4—conduct disorder	0.000135	0.000901	CbGpPWpGaD
Chlorprothixene—DRD1—GPCR ligand binding—HTR2A—conduct disorder	0.000135	0.000895	CbGpPWpGaD
Chlorprothixene—DRD1—Circadian rythm related genes—EP300—conduct disorder	0.000134	0.000888	CbGpPWpGaD
Chlorprothixene—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000134	0.000887	CbGpPWpGaD
Chlorprothixene—DRD3—GPCR ligand binding—HTR2A—conduct disorder	0.000133	0.000883	CbGpPWpGaD
Chlorprothixene—DRD3—Circadian rythm related genes—EP300—conduct disorder	0.000132	0.000876	CbGpPWpGaD
Chlorprothixene—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000131	0.000871	CbGpPWpGaD
Chlorprothixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000131	0.000869	CbGpPWpGaD
Chlorprothixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00013	0.000866	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—CGA—conduct disorder	0.00013	0.000863	CbGpPWpGaD
Chlorprothixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000129	0.000857	CbGpPWpGaD
Chlorprothixene—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	0.000128	0.00085	CbGpPWpGaD
Chlorprothixene—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000125	0.000831	CbGpPWpGaD
Chlorprothixene—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	0.000124	0.000822	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling by GPCR—DRD4—conduct disorder	0.000123	0.000818	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—CGA—conduct disorder	0.000122	0.000814	CbGpPWpGaD
Chlorprothixene—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	0.000122	0.000814	CbGpPWpGaD
Chlorprothixene—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000121	0.000808	CbGpPWpGaD
Chlorprothixene—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000119	0.000793	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—CGA—conduct disorder	0.000118	0.000788	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—CGA—conduct disorder	0.000117	0.000779	CbGpPWpGaD
Chlorprothixene—DRD1—GPCR downstream signaling—DRD4—conduct disorder	0.000117	0.000775	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling by GPCR—DRD4—conduct disorder	0.000116	0.000772	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	0.000115	0.000766	CbGpPWpGaD
Chlorprothixene—DRD3—GPCR downstream signaling—DRD4—conduct disorder	0.000115	0.000765	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling by GPCR—DRD4—conduct disorder	0.000112	0.000747	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—CGA—conduct disorder	0.000112	0.000743	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling by GPCR—DRD4—conduct disorder	0.000111	0.000739	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—CGA—conduct disorder	0.00011	0.000733	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling by GPCR—DRD4—conduct disorder	0.000106	0.000704	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling by GPCR—DRD4—conduct disorder	0.000104	0.000695	CbGpPWpGaD
Chlorprothixene—HTR2A—autonomic nervous system—conduct disorder	0.000104	0.254	CbGeAlD
Chlorprothixene—HTR6—Signaling Pathways—WASF1—conduct disorder	0.000104	0.000691	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000102	0.000676	CbGpPWpGaD
Chlorprothixene—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000101	0.00067	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR ligand binding—HTR2A—conduct disorder	9.98e-05	0.000664	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	9.98e-05	0.000663	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	9.95e-05	0.000661	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	9.92e-05	0.000659	CbGpPWpGaD
Chlorprothixene—CHRM1—Circadian rythm related genes—EP300—conduct disorder	9.87e-05	0.000656	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—CGA—conduct disorder	9.84e-05	0.000654	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	9.82e-05	0.000653	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—WASF1—conduct disorder	9.81e-05	0.000652	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—CGA—conduct disorder	9.56e-05	0.000635	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—WASF1—conduct disorder	9.49e-05	0.000631	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—WASF1—conduct disorder	9.4e-05	0.000625	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling by GPCR—DRD4—conduct disorder	9.06e-05	0.000602	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—WASF1—conduct disorder	8.95e-05	0.000595	CbGpPWpGaD
Chlorprothixene—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	8.84e-05	0.000588	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—WASF1—conduct disorder	8.83e-05	0.000587	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR downstream signaling—DRD4—conduct disorder	8.81e-05	0.000585	CbGpPWpGaD
Chlorprothixene—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	8.66e-05	0.000576	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR downstream signaling—DRD4—conduct disorder	8.65e-05	0.000575	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	8.62e-05	0.000573	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	8.59e-05	0.000571	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	8.51e-05	0.000566	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—CGA—conduct disorder	8.43e-05	0.000561	CbGpPWpGaD
Chlorprothixene—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	8.34e-05	0.000554	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—CGA—conduct disorder	8.3e-05	0.000552	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—CGA—conduct disorder	8.28e-05	0.000551	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—CGA—conduct disorder	8.25e-05	0.000549	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—CGA—conduct disorder	8.23e-05	0.000547	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—CGA—conduct disorder	8.15e-05	0.000542	CbGpPWpGaD
Chlorprothixene—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	8.07e-05	0.000536	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling by GPCR—HTR2A—conduct disorder	8.03e-05	0.000534	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling by GPCR—DRD4—conduct disorder	8e-05	0.000532	CbGpPWpGaD
Chlorprothixene—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	7.99e-05	0.000531	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling by GPCR—DRD4—conduct disorder	7.87e-05	0.000523	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling by GPCR—DRD4—conduct disorder	7.85e-05	0.000522	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling by GPCR—DRD4—conduct disorder	7.83e-05	0.00052	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling by GPCR—DRD4—conduct disorder	7.8e-05	0.000519	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—DRD4—conduct disorder	7.73e-05	0.000514	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—WASF1—conduct disorder	7.66e-05	0.000509	CbGpPWpGaD
Chlorprothixene—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	7.61e-05	0.000506	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	7.57e-05	0.000503	CbGpPWpGaD
Chlorprothixene—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	7.51e-05	0.000499	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	7.33e-05	0.000487	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—DRD4—conduct disorder	7.27e-05	0.000483	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	7.25e-05	0.000482	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling by GPCR—HTR2A—conduct disorder	6.91e-05	0.000459	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—DRD4—conduct disorder	6.86e-05	0.000456	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling by GPCR—HTR2A—conduct disorder	6.82e-05	0.000453	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—WASF1—conduct disorder	6.76e-05	0.000449	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—WASF1—conduct disorder	6.65e-05	0.000442	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—WASF1—conduct disorder	6.64e-05	0.000441	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—DRD4—conduct disorder	6.63e-05	0.000441	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—WASF1—conduct disorder	6.62e-05	0.00044	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—WASF1—conduct disorder	6.59e-05	0.000438	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—DRD4—conduct disorder	6.57e-05	0.000436	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—WASF1—conduct disorder	6.53e-05	0.000434	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	6.51e-05	0.000433	CbGpPWpGaD
Chlorprothixene—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	6.5e-05	0.000432	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—DRD4—conduct disorder	6.26e-05	0.000416	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—CGA—conduct disorder	6.24e-05	0.000415	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—DRD4—conduct disorder	6.17e-05	0.00041	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	5.91e-05	0.000393	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	5.75e-05	0.000382	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	5.64e-05	0.000375	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	5.62e-05	0.000374	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	5.6e-05	0.000373	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	5.55e-05	0.000369	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—DRD4—conduct disorder	5.35e-05	0.000356	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling by GPCR—HTR2A—conduct disorder	5.22e-05	0.000347	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling by GPCR—HTR2A—conduct disorder	5.12e-05	0.000341	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	5.11e-05	0.000339	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	5.09e-05	0.000338	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	5.04e-05	0.000335	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—HTR2A—conduct disorder	4.74e-05	0.000315	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—DRD4—conduct disorder	4.72e-05	0.000314	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—DRD4—conduct disorder	4.65e-05	0.000309	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—DRD4—conduct disorder	4.64e-05	0.000308	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—DRD4—conduct disorder	4.62e-05	0.000307	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—DRD4—conduct disorder	4.61e-05	0.000306	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—DRD4—conduct disorder	4.56e-05	0.000303	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—HTR2A—conduct disorder	4.47e-05	0.000297	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—COMT—conduct disorder	4.44e-05	0.000295	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—MAOA—conduct disorder	4.41e-05	0.000293	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—HTR2A—conduct disorder	4.33e-05	0.000288	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—HTR2A—conduct disorder	4.28e-05	0.000285	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—HTR2A—conduct disorder	4.08e-05	0.000271	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—HTR2A—conduct disorder	4.03e-05	0.000268	CbGpPWpGaD
Chlorprothixene—CHRM4—brain—conduct disorder	3.88e-05	0.0948	CbGeAlD
Chlorprothixene—DRD3—brain—conduct disorder	3.61e-05	0.0881	CbGeAlD
Chlorprothixene—HTR2C—Signaling Pathways—HTR2A—conduct disorder	3.49e-05	0.000232	CbGpPWpGaD
Chlorprothixene—HTR6—brain—conduct disorder	3.47e-05	0.0848	CbGeAlD
Chlorprothixene—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.08e-05	0.000205	CbGpPWpGaD
Chlorprothixene—CHRM5—brain—conduct disorder	3.03e-05	0.0741	CbGeAlD
Chlorprothixene—HRH1—Signaling Pathways—HTR2A—conduct disorder	3.03e-05	0.000201	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—HTR2A—conduct disorder	3.02e-05	0.000201	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—HTR2A—conduct disorder	3.01e-05	0.0002	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—HTR2A—conduct disorder	2.98e-05	0.000198	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—COMT—conduct disorder	2.82e-05	0.000187	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—MAOA—conduct disorder	2.8e-05	0.000186	CbGpPWpGaD
Chlorprothixene—DRD1—brain—conduct disorder	2.58e-05	0.0631	CbGeAlD
Chlorprothixene—HTR6—Signaling Pathways—EP300—conduct disorder	2.51e-05	0.000167	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—EP300—conduct disorder	2.37e-05	0.000158	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—EP300—conduct disorder	2.29e-05	0.000152	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—EP300—conduct disorder	2.27e-05	0.000151	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—EP300—conduct disorder	2.16e-05	0.000144	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—EP300—conduct disorder	2.13e-05	0.000142	CbGpPWpGaD
Chlorprothixene—CHRM2—brain—conduct disorder	2.08e-05	0.0508	CbGeAlD
Chlorprothixene—HTR2C—brain—conduct disorder	2.01e-05	0.049	CbGeAlD
Chlorprothixene—CHRM3—Metabolism—EP300—conduct disorder	1.91e-05	0.000127	CbGpPWpGaD
Chlorprothixene—CHRM1—brain—conduct disorder	1.89e-05	0.0463	CbGeAlD
Chlorprothixene—HTR2B—brain—conduct disorder	1.88e-05	0.046	CbGeAlD
Chlorprothixene—HTR2C—Signaling Pathways—EP300—conduct disorder	1.85e-05	0.000123	CbGpPWpGaD
Chlorprothixene—CHRM3—brain—conduct disorder	1.7e-05	0.0414	CbGeAlD
Chlorprothixene—DRD2—Signaling Pathways—EP300—conduct disorder	1.63e-05	0.000109	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—EP300—conduct disorder	1.61e-05	0.000107	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—EP300—conduct disorder	1.6e-05	0.000107	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—EP300—conduct disorder	1.6e-05	0.000106	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—EP300—conduct disorder	1.59e-05	0.000106	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—EP300—conduct disorder	1.58e-05	0.000105	CbGpPWpGaD
Chlorprothixene—DRD2—brain—conduct disorder	1.53e-05	0.0373	CbGeAlD
Chlorprothixene—ABCB1—Metabolism—EP300—conduct disorder	1.21e-05	8.04e-05	CbGpPWpGaD
Chlorprothixene—HRH1—brain—conduct disorder	1.2e-05	0.0294	CbGeAlD
Chlorprothixene—HTR2A—brain—conduct disorder	1.01e-05	0.0246	CbGeAlD
Chlorprothixene—ABCB1—brain—conduct disorder	6.59e-06	0.0161	CbGeAlD
